Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Zosano Pharma (ZSAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Zosano Pharma Reports First Quarter 2019 Financial Results

-- Multiple catalysts, including Qtrypta NDA submission, anticipated in 2019

ZSAN : 2.73 (-1.09%)
Zosano Pharma Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 14, 2019 / Zosano Pharma Corp. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 14, 2019 at 4:30 PM Eastern Time....

ZSAN : 2.73 (-1.09%)
Zosano Announces Full Exercise of Underwriter's Option to Purchase Additional Shares

Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has issued and sold an additional 750,000 shares of common stock, pursuant to the exercise in...

ZSAN : 2.73 (-1.09%)
Zosano Pharma to Host Conference Call on First Quarter 2019 Financial Results and Provide Operational Update

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and webcast on Tuesday, May 14, 2019 at 4:30 p.m. ET to discuss...

ZSAN : 2.73 (-1.09%)
Biotech Brief: FDA Fast Tracking Innovative Breakthrough Therapies For Cancer Patients

A recent headline from a report released by Friends of Cancer Research, made the following eye-opening statement: "ONE OF THE BIGGEST TREATMENT BREAKTHROUGHS IN THE PAST FIVE YEARS WASN'T A DRUG, BUT A...

WVE : 25.41 (+5.04%)
ZSAN : 2.73 (-1.09%)
BPTH : 14.54 (-0.82%)
PFE : 41.95 (+0.07%)
MBRX : 1.11 (-0.89%)
Zosano Announces the Publication of an Analysis of Acute Treatments for Migraine in Headache: The Journal of Head and Face Pain

Zosano Pharma Corporation (NASDAQ:ZSAN) ("Zosano" or the "Company"), a clinical-stage biopharmaceutical company, today announced the peer-reviewed publication of a review and analysis of recently-completed...

ZSAN : 2.73 (-1.09%)
New Research Coverage Highlights Franklin Resources, Corporate Office Properties Trust, Guidewire Software, Bemis, T2 Biosystems, and Zosano Pharma -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Franklin Resources, Inc. (NYSE:BEN),...

GWRE : 105.74 (+0.51%)
TTOO : 2.10 (+0.96%)
BMS : 57.40 (+0.26%)
BEN : 33.28 (+0.36%)
ZSAN : 2.73 (-1.09%)
OFC : 28.14 (+0.18%)
Zosano Announces Pricing of Public Offering of Common Stock

Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of its common stock for gross proceeds of $17.5 million,...

ZSAN : 2.73 (-1.09%)
Zosano Pharma Announces Proposed Public Offering of Common Stock

Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares...

ZSAN : 2.73 (-1.09%)
Transdermal/Transmucosal Drug Delivery System Market Size, Growth Opportunities, Trends by Manufacturers, Regions, Application & Forecast to 2024

Market Study Report newly added the Global Transdermal/Transmucosal Drug Delivery System Market Report that gives meticulous investigation of current scenario of the market size, share, demand, growth,...

DRRX : 0.60 (unch)
ATRS : 2.93 (+3.17%)
CORI : 12.68 (+0.24%)
ZSAN : 2.73 (-1.09%)
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year ended December 31, 2018, as well as...

ZSAN : 2.73 (-1.09%)
Zosano Pharma Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 14, 2019 / Zosano Pharma Corp. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 14, 2019, 2018 at 4:30 PM...

ZSAN : 2.73 (-1.09%)
Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief executive officer, John Walker, will participate in a panel titled...

ZSAN : 2.73 (-1.09%)
Zosano Pharma to Host Conference Call on Fourth Quarter and Full Year 2018 Financial Results and Provide Operational and Strategic Update

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and webcast on Thursday, March 14, 2019 at 4:30 p.m. ET to discuss...

ZSAN : 2.73 (-1.09%)
Detailed Research: Economic Perspectives on Zosano Pharma, Appian, Ross Stores, Alleghany, ZAGG, and Lindsay -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Zosano Pharma Corporation (NASDAQ:ZSAN),...

APPN : 34.70 (+2.12%)
ROST : 92.78 (-1.83%)
Y : 685.85 (+0.18%)
ZSAN : 2.73 (-1.09%)
LNN : 77.31 (-0.40%)
ZAGG : 6.85 (+5.06%)
Thinking about buying stock in Apple, Canopy Growth Corp, Immune Design, Roku Inc or Zosano Pharma?

InvestorsObserver issues critical PriceWatch Alerts for AAPL, CGC, IMDZ, ROKU, and ZSAN.

ROKU : 95.78 (+6.45%)
AAPL : 178.97 (-0.38%)
IMDZ : 5.85 (unch)
ZSAN : 2.73 (-1.09%)
Zosano Appoints Linda Grais M.D., J.D. to Board of Directors

Zosano Pharma Corporation (NASDAQ:ZSAN) ("Zosano" or the "Company"), a clinical-stage biopharmaceutical company, today announced the appointment of Linda Grais, M.D., J.D. to its board of directors.

LLY : 116.79 (-0.02%)
ABIO : 6.97 (-0.57%)
ZSAN : 2.73 (-1.09%)
PRAH : 89.05 (+1.52%)
OCRX : 1.79 (+1.13%)

Van Meerten Stock Picks

NextEra Energy - Large Cap Pick
The Large Cap Pick of the Day is electric utility company NextEra Energy(NEE).
NEE -0.16
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar